Follicular lymphoma (FL) risk is strongly associated with germline genetic variation in human leukocyte antigen (HLA) class II. Cigarette smoking has been suggested to increase FL risk, primarily among women. We hypothesized that amino acids in HLA-antigen D-related β1 subunit (DRB1) interact with smoking in FL risk, as shown for rheumatoid arthritis. We analyzed 373 patients with FL and 818 controls from 2 population-based case-control studies in Sweden and Denmark (1999-2003). Haplotypes in HLA-DRB1 were imputed at amino acid positions 11, 13, 28, 30, and 70-74 (shared epitope). We estimated the relative risk of FL as odds ratios with 95% confidence intervals for different smoking status/haplotype combinations. Interaction was defined as departure from additivity of effects and quantified by the attributable proportion (AP). Relative to never-smokers carrying no shared epitope alleles, smoking was associated with the risk of FL among all subjects (for former smokers, odds ratio (OR) = 2.20, 95% confidence interval (CI): 1.10, 4.41; OR current = 3.56, 95% CI: 1.60, 7.92) and women (OR former = 2.95, 95% CI: 1.18, 7.37; OR current = 5.63, 95% CI: 2.07, 15.3) carrying 2 shared epitope alleles but not among those carrying zero or 1 shared epitope allele. Smoking and shared epitope status interacted significantly as measured by AP (overall, AP = 0.6, 95% CI: 0.15, 1.0; for women, AP = 0.5, 95% CI: 0.005, 1.0). These results suggest a possible interaction between smoking and HLA-DRB1-associated antigen presentation in FL risk and provide a model to further unravel FL etiology.
Genome-wide association studies have revealed risk alleles for follicular lymphoma (FL) in the human leukocyte antigen (HLA) class II region (1) . In particular, amino acids at HLA-antigen D-related β1 subunit (DRB1) positions 11, 13, 28, and 30 are strongly associated with FL risk (2, 3) . The functional significance of these findings is yet to be determined, although they imply a role for antigen presentation (4) . Several studies also suggest that cigarette smoking increases FL risk, primarily among women (5) (6) (7) .
Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint inflammation (8) . From 50% to 70% of affected individuals have antibodies against citrullinated peptides (ACPA) (8, 9) . Amino acids at positions 11, 13, and 70-74 in HLA-DRB1 and cigarette smoking are independent risk factors for ACPA-positive RA (8, 9) . Also, amino acid variants at positions 11, 13, and 70-74 (shared epitope alleles) modify the association between cigarette smoking and ACPA-positive RA (10) (11) (12) .
Given the similar risk patterns for amino acid variation of HLA-DRB1 observed in RA and FL and the fact that these variants interact with smoking in ACPA-positive RA, we hypothesized that the association between smoking and FL risk might be modified by amino acids in HLA-DRB1.
METHODS
We identified 373 incident FL case patients and 142 Danish controls, aged ≥18 years, from the population-based Scandinavian Lymphoma Etiology (SCALE) study (1999) (2000) (2001) (2002) (13) . We also included 676 Swedish controls sampled in 1999-2003 within the population-based Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study (14) . Information on demographic and environmental exposures was collected using standardized questionnaires through a telephone interview (SCALE) or by mail (EIRA). Most respondents provided blood samples (85% of FL cases, 66% of SCALE controls, and 58% of EIRA controls) for preparation of DNA (15) . Complete smoking data was available for all genotyped individuals that remained after quality control filtering (see below). We defined smokers as those smoking cigarettes daily for at least 1 year. Participants were further classified as current smokers if they smoked at the time of FL diagnosis (or the match date) or had stopped <1 year before and as former smokers if they had stopped smoking >1 year prior to FL diagnosis or the match date.
Genotyping of approximately 300,000 single nucleotide polymorphisms in all participants was carried out at the Genome Institute of Singapore (15, 16) . Dense imputation of 71,954 single nucleotide polymorphisms was performed across the HLA region (average info score = 0.97), followed by further imputation of 372 amino acid positions and 263 classical HLA alleles (2) . The accuracy of the imputed genotypes was tested on 92 study samples using Sanger sequencing and 596 EIRA samples that were directly HLA-typed (17) , and it was found to be high (>98% allelic concordance) (2) .
Based on our hypothesis, we first analyzed amino acids in positions 11, 13, 28, 30, and 70-74 for FL risk. Because positions 11, 13, 28, and 30 are linked, we combined them into haplotypes using PHASE, version 2.1 (Web Table 1 , available at http://aje.oxfordjournals.org/) (18) . Shared epitope alleles were defined as HLA-DRB1*01, HLA-DRB1*04, or HLA-DRB1*10, excluding DRB1*0103, DRB1*0402, and DRB1*0403 when 4-digit data was available. Participants were categorized by the number of haplotype alleles carried (0-2). Sixteen haplotype combinations and the shared epitope, present in ≥2% of the study population (Web Table 2 ), were assessed for their association with FL risk. Next, we brought forward haplotype combinations and the shared epitope that were most statistically significantly associated with FL risk (P for trend <5.0 × 10 −4 ) ( Table 1 ), hypothesizing that these would be most functionally relevant and maximizing statistical power.
We used logistic regression models to estimate odds ratios with 95% confidence intervals for main effects of smoking and amino acid haplotypes on FL risk among all subjects (adjusting for country, age, and sex) and among subjects according to sex (adjusting for country and age). Interaction between smoking status and amino acid haplotypes was defined as departure from additivity of effects for the 2 variables on FL risk (see Web Appendix 1 for details), as in RA (10, 11) and as recommended by Rothman et al. (19) . The additive scale allowed us to assess 1) whether there were individuals affected by FL because they both smoked and carried an HLA-DRB1 risk variant, and that otherwise would not have been affected, and 2) whether certain subgroups would benefit more from public health measures such as smoking cessation (20) . Where appropriate, interaction was quantified by the attributable proportion (AP) due to interaction, with 95% confidence intervals (21) . To assess whether RA mediated the potential association, we repeated the analyses excluding study subjects with RA (self-reported and confirmed in medical records). The study was approved by regional ethical review boards in Sweden and Denmark, and all study participants gave written informed consent.
RESULTS
Three haplotype combinations in HLA-DRB1 were associated with FL risk with P for trend <5.0 × 10 −4 : serine11-serine13-aspartate28-tyrosine30 (P for trend = 1.98 × 10
), leucine11-phenylalanine13-glutamate28-cysteine30 (P for trend = 4.82 × 10 −4 ), and the combination of serine11-serine13-aspartate28-tyrosine30 with proline11-arginine13-aspartate28-tyrosine30 (P for trend = 3.71 × 10 −8 ) ( Table 1) . Shared epitope alleles were also associated with FL risk (P for trend = 1.47 × 10 −4 ), consistent with the association for the linked haplotype leucine11-phenylalanine13-glutamate28-cysteine30 (Table 1) .
Current smoking was associated with FL risk with an OR of 1.12 overall and 1.42 among women, but both estimates were nonsignificant (Table 1) . When also considering HLA-DRB1 amino acid variation, smoking was associated with an increased risk of FL among all subjects (for former smokers, odds ratio (OR) = 2.20, 95% confidence interval (CI): 1.10, 4.41; OR current = 3.56, 95% CI: 1.60, 7.92) and among women (OR former = 2.95, 95% CI: 1.18, 7.37; OR current = 5.63, 95% CI: 2.07, 15.3) carrying 2 shared epitope alleles, relative to never-smokers carrying no shared epitope alleles. There was no such increase associated with smoking among all subjects or women carrying no or one shared epitope allele, or among men irrespective of number of shared epitope alleles carried ( Table 2 ). The AP of FL risk due to interaction was 60% among all subjects (AP = 0.6, 95% CI: 0.15, 1.0) and 50% among women (AP = 0.5, 95% CI: 0.005, 1.0) who were current smokers and carried 2 shared epitope alleles (Table 2) . No interaction was detected between other haplotypes and smoking for risk of FL (Web Table 3 ).
After excluding study subjects with verified RA (n = 8), the pattern of associations remained essentially unchanged (for those with 2 shared epitope alleles and current smoking: OR overall = 3.98, 95% CI: 1.30, 6.82; OR women = 4.47, 95% CI: 1.55, 12.8), and AP was significant for all subjects (95% CI: 0.04, 1.0) but not for women (95% CI: −0.3, ≤1.0).
DISCUSSION
In this population-based study, we found evidence to suggest an interaction between cigarette smoking and number of shared epitope alleles in the risk of FL, in line with previous observations in ACPA-positive RA (10-12) and with our hypothesis.
The most statistically significant associations between amino acid haplotypes (serine11-serine13-aspartate28-tyrosine30, leucine11-phenylalanine13-glutamate28-cysteine30, and proline11-arginine13-aspartate28-tyrosine30) and FL risk observed in this study are in line with previous studies Abbreviations: C, cysteine; CI, confidence interval; D, aspartate; DRB1, antigen D-related β1 subunit; E, glutamate; F, phenylalanine; HLA, human leukocyte antigen; L, leucine; OR, odds ratio; P, proline; R, arginine; S, serine; Y, tyrosine.
a Associations estimated as odds ratio with 95% confidence interval. Regression models were adjusted for country, age, and (in overall analysis only) sex.
b Haplotype combinations associated with risk of follicular lymphoma with P for trend ≤5.0 × 10 −4 overall are presented.
c Among carriers of 1 and 2 S11-S13-D28-Y30/P11-R13-D28-Y30 alleles, 50% and 0%, respectively, also carried 1 shared epitope allele and 0% carried 2 shared epitope alleles.
d Among carriers of one L11-F13-E28-C30 allele, 76% carried 1 shared epitope allele, and 23% carried 2 shared epitope alleles; among carriers of 2 L11-F13-E28-C30 alleles, 100% carried 2 shared epitope alleles.
e Among carriers of 1 shared epitope allele, 38% carried 1 and 0% carried 2 L11-F13-E28-C30 alleles; among carriers of 2 shared epitope alleles, 46% carried 1 and 14% carried 2 L11-F13-E28-C30 alleles. Shared epitope alleles were defined as HLA-DRB1*01, HLA-DRB1*04 or HLA-DRB1*10, excluding DRB1*0103, DRB1*0402 and DRB1*0403 when 4-digit data was available. c AP of interaction is presented for individuals exposed to both current smoking and 2 shared epitope alleles.
of amino acid variation in single positions (2, 3) . These haplotypes correspond to classical allelic groups: the pooled HLA-DRB1*03, *11, *13 and *14 group; the HLA-DRB1*01 group; and the pooled HLA-DRB1*15 and *16 group, respectively (Web Table 1 ). Although smoking was not statistically significantly associated with FL risk in this study, the odds ratios (OR overall = 1.12; OR women = 1.42) ( Table 1) were practically the same as previously reported from the SCALE study (OR overall = 1.15, 95% CI: 0.91, 1.44; OR women = 1.41, 95% CI: 1.04, 1.92) (7) and similar to those from a large study from the InterLymph Consortium (OR overall = 1.19, 95% CI: 1.07, 1.32; OR women = 1.22, 95% CI: 1.09, 1.37) (6) .
The present results suggest that the previously reported positive association between smoking and FL risk (6, 7) may be restricted to individuals with certain amino acid haplotypes in the HLA-DRB1 region, either the shared epitope or closely linked positions. Although our results indicate the possibility of a difference by sex, further work in larger studies is needed to validate such a difference, if it exists. Amino acid positions 70-74 are located on the wall of the HLA-DRB1 antigen-binding groove, and positions 11, 13, 28, and 30 are located on the floor (Web Figure 1) , where they directly interact with antigens presented to helper T cells (4) . It is unclear how smoking and amino acid variation in HLA-DRB1 might interact biologically in FL pathogenesis, although the current results suggest that presentation of antigens influenced by smoking may be dependent on the presence of specific amino acids in the antigen-binding groove. Long-term smoking causes continuous release of intracellular antigens (22) . Presentation of these antigens to helper T cells might be augmented in antigen-presenting cells carrying shared epitope-containing HLA-DRB1 variants (or some other closely linked variant) and lead to sustained B-cell activation (22) . Such an enhanced chronic stimulation of B cells may strengthen signals to survive and proliferate (23) , resulting in increased risk of malignant transformation (24) .
To our knowledge, this is the first study to investigate a possible interaction between smoking and HLA variation as a means to shed further light on FL etiology. Although our analyses were based on comprehensive imputation of amino acid haplotypes with high confidence (BEAGLE r 2 = 0.97) (http://faculty.washington.edu/browning/beagle/beagle.html) (2), there might have been minor inaccuracies in single nucleotide polymorphism calling. Also, the precision of our analyses was sometimes limited by few observations for some smoking/ haplotype combinations. However, we expect these potential biases to affect cases and controls equally, reducing power but not leading to an increased risk of false positive results.
In conclusion, this study supports the hypothesis of cigarette smoking as a risk factor for FL and further suggests that the association may be restricted to individuals carrying certain HLA-DRB1 amino acid haplotypes.
